Benjamin Edwards Inc Exact Sciences Corp Transaction History

Benjamin Edwards Inc

$503 Million
Q1 2024

A detailed history of Benjamin Edwards Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Benjamin Edwards Inc holds 75 shares of EXAS stock, worth $3,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 109 31.19%

Holding current value

$3,306

Previous $8,000 37.5%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$56.27 - $73.77 $1,913 - $2,508	-34 Reduced 31.19%	75 $5,000
Q4 2023 Feb 06, 2024	SELL	$59.06 - $75.72 $34,195 - $43,841	-579 Reduced 84.16%	109 $8,000
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $2,110 - $3,169	-32 Reduced 4.44%	688 $47,000
Q2 2023 Aug 15, 2023	SELL	$62.68 - $95.05 $17,738 - $26,899	-283 Reduced 28.22%	720 $68,000
Q1 2023 Apr 27, 2023	SELL	$47.19 - $70.77 $16,280 - $24,415	-345 Reduced 25.59%	1,003 $68,000

Q4 2022 Feb 07, 2023	BUY	$30.35 - $53.15 $5,038 - $8,822	166 Added 14.04%	1,348 $67,000
Q3 2022 Oct 28, 2022	BUY	$31.97 - $49.37 $127 - $197	4 Added 0.34%	1,182 $38,000
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $712 - $1,524	20 Added 1.73%	1,178 $46,000
Q1 2022 May 04, 2022	BUY	$57.56 - $82.54 $690 - $990	12 Added 1.05%	1,158 $81,000
Q4 2021 Feb 07, 2022	BUY	$72.5 - $100.68 $45,820 - $63,629	632 Added 122.96%	1,146 $89,000
Q3 2021 Nov 02, 2021	BUY	$90.24 - $124.05 $4,241 - $5,830	47 Added 10.06%	514 $49,000
Q2 2021 Aug 11, 2021	BUY	$93.66 - $139.27 $10,115 - $15,041	108 Added 30.08%	467 $58,000
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $6,294 - $8,370	54 Added 17.7%	359 $47,000
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $30,381 - $43,346	305 New	305 $40,000

Others Institutions Holding EXAS

# of Institutions

700

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.8B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Exact Sciences Corp Transaction History